皮埃佐1的功能增益突变通过破坏心肌脂质平衡,以及铁过载,驱动心肌病
Cuiqin Fan1,2,3,4,5, Han Du1,2,3,4,5, Song Sun1,2,3,4,5
1Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Science advances
|November 14, 2025
概括
功能获取PIEZO1突变通过CaMKII和FOXO3破坏心脏脂质代谢,导致心肌病. 这一发现将焦点从铁过载转移到心脏病遗传学中的PIEZO1.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 机械生物学 机械生物学
背景情况:
- 心肌细胞中的PIEZO1通道介导机械拉伸到Ca2+信号传递,这对于弗兰克-斯塔林机制和心力衰竭补偿至关重要.
- 皮埃佐1突变在心肌病发展中的作用尚不清楚,尽管有个案例将皮埃佐1变异与心肌铁沉积与心力衰竭联系在一起.
研究的目的:
- 调查PIEZO1功能增益 (GOF) 突变对心脏功能的影响,并确定潜在的分子机制.
- 探索PIEZO1突变,脂质代谢和心肌病发展之间的关系.
主要方法:
- 使用PIEZO1功能增益 (GOF) 突变D674Y的小鼠模型和特定于心肌细胞的Piezo1过度表达系统.
- 采用单细胞RNA测序来分析心肌细胞中的基因表达变化.
- 研究了涉及Ca2+,CaMKII和FOXO3.3的信号通路
主要成果:
- 在小鼠和心肌细胞中发生的PIEZO1GOF突变导致心脏功能受损,并诱导铁过载.
- 单细胞RNA测序揭示了PIEZO1 GOF.在心肌细胞中抑制的脂质代谢途径.
- 皮埃佐1GOF增加了细胞内Ca2+,激活了CaMKII,导致FOXO3降低调节并破坏了脂质代谢.
结论:
- PIEZO1 GOF突变通过CaMKII-FOXO3通路破坏心肌脂代谢,从而导致心肌病.
- 这项研究强调了PIEZO1作为心肌病的潜在遗传因素,挑战了对铁相关机制的单一关注.
- PIEZO1值得考虑未来对心肌病患者进行遗传查.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
01:21Myocarditis I: Introduction
354
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
354
01:30Cardiomyopathy II: Dilated Cardiomyopathy
451
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
01:25Cardiomyopathy I: Introduction and Classification
488
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
488
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
438
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
438